Sex Differences in Morton's Extension Application on Plantar Pressure Distribution in Different Foot Regions in Female and Male Patients Without Deformities: A Pre-Post Test Study

March 5, 2025 updated by: EVA MARIA MARTÍNEZ JIMENEZ, Mayuben Private Clinic

Comparison of the Effect of a Morton's Extension on Plantar Pressure Distribution in Different Foot Regions in Female and Male Patients Without Deformities: A Pre-Post Test Study

The aim of this study is to simulate the orthopedic treatment called Morton's extension on non-deformed patients to check the different effects producted by sex in footprint.

Study Overview

Status

Completed

Conditions

Detailed Description

The objective of this study is to perform an assimilation of the orthopedic treatment called morton extension on non-deformed patients to verify the difference effects due by sex on each metatarsal head and rearfoot on its static footprint, and plantar pressures variables in dynamic footprint.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Manresa, Barcelona, Spain, 28702
        • Anna Sanchez-Serena

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • no history of trauma to the foot;
  • the presence of at least 10° of dorsiflexion at the ankle with the knee fully dorsiflexed;
  • unrestricted motion of the functional subtalar joint of 30°;
  • unrestricted motion along the longitudinal axis of the midtarsal joint of 15°;
  • unrestricted nonweight-bearing motion of the first ray of at least 8 mm;
  • greater than 50° of dorsiflexion of the hallux to the first metatarsal bisection during nonweight-bearing;
  • age greater than 18 years and younger than 60 years;
  • at the time of data collection, no lower limb dysfunction or chronic injury; and
  • no evidence of a non-fixed deformity at first metatarsophalangeal and first metatarsal cuneiform joints.

Exclusion Criteria:

  • plantar corns and calluses,
  • hallux valgus and lesser toe deformities,
  • diabetes,
  • any abnormality in the lower extremity that may affect gait.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Women
A Morton extension with a height of 5 mm was insert from the proximal area of the first metatarsal head to the base of the proximal phalanx of the Hallux.
Morton extension application
Other Names:
  • Orthopaedics
Experimental: Men
A Morton extension with a height of 5 mm was insert from the proximal area of the first metatarsal head to the base of the proximal phalanx of the Hallux.
Morton extension application
Other Names:
  • Orthopaedics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
After Morton Extension Maximum pressure
Time Frame: Through study completion, an average of 1 week
Static footprint will measure maximum plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa). Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
Through study completion, an average of 1 week
Before Morton Extension Medium pressure
Time Frame: Through study completion, an average of 1 week.
Static footprint will measure medium plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa). Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
Through study completion, an average of 1 week.
Extension Maximum pressure
Time Frame: Through study completion, an average of 1 week.
Static footprint will measure maximum plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa). Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
Through study completion, an average of 1 week.
After Morton Extension Medium pressure
Time Frame: Through study completion, an average of 1 week.
Static footprint will measure medium plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa). Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
Through study completion, an average of 1 week.
Before Morton Extension Medium pressure
Time Frame: Through study completion, an average of 1 week
Dynamic footprint will measure medium plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa). Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
Through study completion, an average of 1 week
Before Morton Extension Maximum pressure
Time Frame: Through study completion, an average of 1 week
Dynamic footprint will measure maximum plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa). Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
Through study completion, an average of 1 week
After Morton Extension Medium pressure
Time Frame: Through study completion, an average of 1 week
Dynamic footprint will measure medium plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa). Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
Through study completion, an average of 1 week
After Morton Extension Maximum pressure
Time Frame: Through study completion, an average of 1 week
Dynamic footprint will measure maximum plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa). Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
Through study completion, an average of 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2025

Primary Completion (Actual)

March 1, 2025

Study Completion (Actual)

March 5, 2025

Study Registration Dates

First Submitted

November 29, 2024

First Submitted That Met QC Criteria

December 3, 2024

First Posted (Actual)

December 4, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 5, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20/235(B)-E

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Womens with Morton´s Extension

Subscribe